awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34628840-4E8B5043-9A89-4F91-A1EF-E943CEC6D519
Q34628840-4E8B5043-9A89-4F91-A1EF-E943CEC6D519
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34628840-4E8B5043-9A89-4F91-A1EF-E943CEC6D519
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.
P2860
Q34628840-4E8B5043-9A89-4F91-A1EF-E943CEC6D519
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34628840-4E8B5043-9A89-4F91-A1EF-E943CEC6D519
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
54ea2b0dc73ff9e5aee7a864b9a0705826f517a1
P2860
Absence of progression as assessed by response evaluation criteria in solid tumors predicts survival in advanced GI stromal tumors treated with imatinib mesylate: the intergroup EORTC-ISG-AGITG phase III trial.